Confluence Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$409K Sell
3,654
-92
-2% -$14.2K 0.2% 91
2020
Q2
$615K Buy
3,746
+116
+3% +$17.8K 0.29% 69
2020
Q1
$504K Sell
3,630
-24
-0.7% -$3.3K 0.28% 74
2019
Q4
$480K Hold
3,654
0.22% 86
2019
Q3
$409K Buy
3,654
+143
+4% +$15.9K 0.2% 91
2019
Q2
$389K Sell
3,511
-127
-3% -$15K 0.19% 93
2019
Q1
$472K Buy
3,638
+319
+10% +$38.8K 0.23% 82
2018
Q4
$384K Sell
3,319
-235
-7% -$26.3K 0.21% 83
2018
Q3
$381K Hold
3,554
0.2% 94
2018
Q2
$303K Buy
3,554
+26
+0.7% +$2.14K 0.16% 100
2018
Q1
$273K Sell
3,528
-1,881
-35% -$151K 0.14% 107
2017
Q4
$457K Hold
5,409
0.22% 86
2017
Q3
$463K Buy
5,409
+140
+3% +$11.5K 0.23% 84
2017
Q2
$434K Sell
5,269
-89
-2% -$7.26K 0.21% 87
2017
Q1
$451K Buy
5,358
+176
+3% +$14.1K 0.22% 82
2016
Q4
$381K Sell
5,182
-290
-5% -$21.6K 0.19% 95
2016
Q3
$439K Buy
5,472
+447
+9% +$35.8K 0.21% 93
2016
Q2
$396K Buy
5,025
+244
+5% +$18.4K 0.2% 96
2016
Q1
$344K Buy
4,781
+153
+3% +$11.6K 0.16% 107
2015
Q4
$390K Buy
4,628
+235
+5% +$19.5K 0.19% 98
2015
Q3
$368K Buy
4,393
+170
+4% +$14.4K 0.2% 93
2015
Q2
$353K Buy
4,223
+14
+0.3% +$1.07K 0.19% 89
2015
Q1
$306K Buy
4,209
+53
+1% +$3.77K 0.18% 90
2014
Q4
$287K Sell
4,156
-107
-3% -$7.22K 0.18% 80
2014
Q3
$276K Sell
4,263
-319
-7% -$20.2K 0.19% 78
2014
Q2
$285K Buy
4,582
+576
+14% +$34.4K 0.16% 107
2014
Q1
$236K Buy
+4,006
New +$224K 0.18% 80

Other funds holding LLY

Confluence Wealth Management's LLY Position: Q3 2020 in Review

Confluence Wealth Management reduced its Eli Lilly (LLY) stake by 2.5% in Q3 2020, selling an estimated $14.2K and leaving 3,654 shares worth $409K. The position accounts for 0.2% of the portfolio, ranked #91.

Confluence Wealth Management first reported a position in LLY in Q1 2014 and has held it in 27 quarters since. The position peaked at $615K in Q2 2020. 1,773 funds tracked by Wall St. Rank hold LLY as of Q3 2020.

  • Confluence Wealth Management held 3,654 shares of Eli Lilly worth $409K as of Q3 2020.
  • Confluence Wealth Management sold 92 Eli Lilly shares in Q3 2020, an estimated $14.2K.
  • Eli Lilly made up 0.2% of Confluence Wealth Management's portfolio in Q3 2020, its #91 holding.
  • Confluence Wealth Management first reported a position in Eli Lilly in Q1 2014 and has held it in 27 quarters since.
  • Confluence Wealth Management's Eli Lilly position peaked at $615K in Q2 2020.
  • 1,773 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2020.

Based on Confluence Wealth Management's 13F filing for Q3 2020, filed 26 Oct 2020.